# Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

> **NCT02487173** · NA · COMPLETED · sponsor: **Ellume Pty Ltd** · enrollment: 83 (actual)

## Conditions studied

- Influenza A
- Influenza B

## Interventions

- **DEVICE:** Respirio Flu Test
- **DEVICE:** Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
- **DEVICE:** Sofia® Influenza A+B Fluorescent Immunoassay (FIA)

## Key facts

- **NCT ID:** NCT02487173
- **Lead sponsor:** Ellume Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02487173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02487173, "Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02487173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*